Quantification of Etoricoxib in Low Plasma Volume by UPLC-PDA and Application to Preclinical Pharmacokinetic Study
Open Access
- 16 April 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (4) , 507
Abstract
An ultra-performance liquid chromatography with photodiode array (UPLC-PDA) UV detection method was developed here for the first time for simple, rapid, selective and sensitive quantification of the commonly prescribed selective cyclooxygenase-2 (COX-2) inhibitor etoricoxib in low plasma volumes (50 μL). The method includes protein precipitation followed by liquid–liquid extraction, evaporation and reconstitution. A gradient mobile phase of 75:25 going to 55:45 (v/v) water:acetonitrile (1 mL/min flow rate) was applied. Total run time was 8 min, representing a significant improvement relative to previous reports. Excellent linearity (r2 = 1) was obtained over a wide (0.1–12 µg/mL) etoricoxib concentration range. Short retention times for etoricoxib (4.9 min) and the internal standard trazodone (6.4 min), as well as high stability, recovery, accuracy, precision and reproducibility, and low etoricoxib LOD (20 ng/mL) and LOQ (100 ng/mL), were achieved. Finally, the method was successfully applied to a pharmacokinetic study (single 20 mg/kg orally administered etoricoxib mini-capsule) in rats. In conclusion, the advantages demonstrated in this work make this analytical method both time- and cost-efficient for drug monitoring in pre-clinical/clinical settings.Keywords
Funding Information
- Israeli Ministry of Innovation, Science and Technology (MOST) (0006031)
This publication has 29 references indexed in Scilit:
- Challenges and Opportunities for Celecoxib RepurposingPharmaceutical Research, 2023
- Association of Etoricoxib treatment and incident hypoxia in patients with aortic dissection undergoing endovascular aortic repairBiomedicine & Pharmacotherapy, 2021
- Etoricoxib treatment prevented body weight gain and ameliorated oxidative stress in the liver of high-fat diet–fed ratsNaunyn-Schmiedeberg's Archives of Pharmacology, 2020
- Etoricoxib-loaded bio-adhesive hybridized polylactic acid-based nanoparticles as an intra-articular injection for the treatment of osteoarthritisInternational Journal of Pharmaceutics, 2020
- Rapid quantitative analysis of etoricoxib in human plasma by UPLC‐MS/MS and application to a pharmacokinetic study in Chinese healthy volunteersBiomedical Chromatography, 2018
- Effects of the highly COX-2-selective analgesic NSAID etoricoxib on the rate of orthodontic tooth movement and cranial growthAnnals of Anatomy - Anatomischer Anzeiger, 2018
- Single dose oral etoricoxib for acute postoperative pain in adultsCochrane Database of Systematic Reviews, 2014
- Quantification of carbamazepine and its 10,11‐epoxide metabolite in rat plasma by UPLC‐UV and application to pharmacokinetic studyBiomedical Chromatography, 2013
- Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high‐performance liquid chromatography with UV detectionBiomedical Chromatography, 2005
- Simultaneous determination of unlabeled and carbon‐13‐labeled etoricoxib, a new cyclooxygenase‐2 inhibitor, in human plasma using HPLC–MS/MSJournal of Pharmaceutical Sciences, 2002